BioSpace News Archive

Press Releases

Tandem Diabetes Care Announces Upcoming Conference Participation

October 31, 2024
·
1 min read
Press Releases

Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024

October 31, 2024
·
12 min read
Press Releases

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

October 31, 2024
·
26 min read
Press Releases

Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab

October 31, 2024
·
5 min read
Press Releases

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

October 31, 2024
·
6 min read
Press Releases

NRG Therapeutics Selects First Development Candidate, NRG5051, and Secures Grant from The Michael J. Fox Foundation for Development of mPTP Inhibitors to Treat Neurodegenerative Diseases

October 31, 2024
·
4 min read
Press Releases

AiCuris Initiates First-in-Human Phase 1 Trial With Antiviral Agent AIC468 to Address BK Virus Infections in Kidney Transplant Recipients

October 31, 2024
·
2 min read
Press Releases

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

October 31, 2024
·
4 min read
Press Releases

Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic

October 31, 2024
·
5 min read
Press Releases

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality

October 31, 2024
·
7 min read